glp-1 adoption GLP-1s in 2025: Who's Using Them, Who's Covering Them, and What's Next GLP-1 adoption forces CPGs to

GLP-1s (full name: glucagon-like peptide-1 receptor agonists, or GLP-1 agonists) help the pancreas release insulin, reduce blood sugar, slow the rate of stomach emptying, and increase feelings of fullness, explains Gretchen Zimmermann, RD, a registered dietitian specializing in obesity and vice president of clinical strategy at Vida Health

Coverage decisions that felt settled six months ago are being revisited as organizations gain visibility into actual utilization, adherence, and cost trends

Shared decision-making between patients and providers, with clear communication about known risks and uncertainties, remains essential for safe and appropriate use of this medication

Its essential for the brain and nervous systems health

Folks often go for trusted brands, which has got a solid rep for consistently getting their goods and services to you on time